T cell receptors (TCR) and major histocompatibility complex (MHC) molecules are integral membrane proteins that have central roles in cell-mediated immune recognition. Therefore, soluble analogs of these molecules would be useful for analyzing and possibly modulating antigen-specific immune responses. However, due to the intrinsic low-affinity and inherent solubility problems, it has been difficult to produce soluble high-affinity analogs of TCR and class II MHC molecules. This report describes a general approach which solves this intrinsic low-affinity by constructing soluble divalent analogs using IgG as a molecular scaffold. The divalent nature of the complexes increases the avidity of the chimeric molecules for cognate ligands. The generality of this approach was studied by making soluble divalent analogs of two different classes of proteins, a TCR (2C TCR 2 Ig) and a class II MHC ( MCC I-E k 2 Ig) molecule. Direct flow cytometry assays demonstrate that the divalent 2C TCR 2 Ig chimera retained the specificity of the native 2C TCR, while displaying increased avidity for cognate peptide/MHC ligands, resulting in a high-affinity probe capable of detecting interactions that heretofore have only been detected using surface plasmon resonance. TCR 2 IgG was also used in immunofluorescence studies to show ER localization of intracellular peptide-MHC complexes after peptide feeding.
INTRODUCTION
Specificity of recognition is a cardinal feature of the immune system. This specificity is dictated, at the molecular level, by the interactions between T cell receptors (TCR) on T cells and peptide/major histocompatibility complexes (pepMHC) on antigen-presenting cells. A variety of assays including both site-directed mutagenesis and crystal structure analyses indicate that specific TCR recognition of pepMHC is based on direct contacts with both the MHC and the antigenic peptide it binds (1) (2) (3) . This recognition is the first step in the initiation of the T cell arm of the immune response. Therefore, TCR/pepMHC interactions are crucial in influencing effector T cell responses.
Reagents able to detect and/or regulate cells bearing specific TCR or peptide/MHC complexes would be of great utility given the centrality of TCR-pepMHC interactions in antigen-specific cell-mediated immunity. Inherent specificity and the potential ability to engage cognate ligands in a physiologically relevant manner suggest that soluble analogs of TCR and pepMHC complexes could be ideal probes to study immune responses. However, there are two problems with the generation and use of soluble analogs of TCR and class II MHC molecules. First, soluble analogs of TCR and class II MHC are difficult to produce since these protein complexes consist of two polypeptides each of which have transmembrane domains. These transmembrane domains are important in facilitating pairing and hence proper folding of the ␣ and ␤ polypeptides. The second problem with the use of soluble analogs of TCR and class II MHC molecules is that the ability to use these probes is limited by their intrinsic low affinity.
Despite the technical difficulties involved in generating such complexes, in several instances soluble complexes have been produced (4 -12) . However, the utility of these probes is limited by their intrinsic low affinity for cognate ligands. In contrast, due to their increased avidity, multivalent constructs of TCR or peptide/MHC are valuable probes for detection of their ligands (13) (14) (15) (16) .
In this report we describe the construction and activity of soluble, divalent TCR and MHC class II analogs. Biochemical and biological analysis of these soluble, divalent TCR (TCR 2 Ig) and MHC class II (class II 2 Ig) analogs suggests that they may be of great utility as specific, high-affinity probes of the immune system. Furthermore, the potentially broad applicability of this expression system for making divalent, soluble analogs of heterodimeric integral membrane proteins with increased avidity for cognate ligand suggest its use in a range of biological systems.
MATERIAL AND METHODS

Construction of the Soluble Divalent Molecules
The genes encoding the chimeric 2C TCR 2 Ig molecule were constructed by inserting cDNA encoding the extracellular domains of the TCR ␣ and ␤ chains upstream of cDNA encoding the murine IgG1 heavy, 93G7, and light chain, 91A3, respectively (Fig. 1A) (17) . A HindIII restriction enzyme site and linker were inserted immediately 5Ј of the codon for Asp at the start of the mature protein in clone 91A3. A KpnI restriction enzyme site was introduced 3Ј of the stop codon in the polypeptide. A KpnI restriction site and linker were inserted immediately 5Ј of the codon for Glu lo-
FIG. 1.
Expression vector and theoretical structure of X/Ig chimeric polypeptide chains. (A) In the generic cloning vector, DNA-encoding ␣ and ␤ chains of extracellular domains of either class II or TCR proteins were ligated to DNA-encoding Ig heavy and light chains using the restriction endonuclease sites shown. Subsequently, these chimeras were ligated sequentially to a modified pAcUW51 vector (18) . (B) Theoretical structure of a soluble, divalent Ig chimeric complex. (C) Computer-generated model of the peptide backbone of 2C TCR 2 Ig. The model is based on the crystal structures of an intact IgG1 (42) and the 2C TCR (3). The six amino acid linkers have been modeled into the structure. The IgG1 heavy chains are shown in green; the light chains, in yellow; the 2C TCR ␣ chains, in blue; the 2C TCR ␤ chains, in red; and the linker peptides, in white. The arrows point to (from top to bottom) the pepMHC-binding site on the TCR, the linker region, and the IgG hinge region.
cated at the start of the mature Ig␥ 1 polypeptide in clone 93G7. An SphI restriction site was introduced 3Ј to the stop codon in the ␥ 1 polypeptide.
The genes encoding the 2C TCR ␣ and ␤ chains have previously been described (4) . A KpnI restriction site and linker was inserted immediately 3Ј to the codon for the Gln residue at the interface between the extracellular and transmembrane domains of the 2C TCR ␣ polypeptide. The 5Ј regions of the gene already expressed an appropriate restriction enzyme endonuclease site, EcoRI. A Xho1 site was introduced 5Ј to the start of the signal sequence in the 2C TCR ␤ chain and a HindIII restriction enzyme endonuclease site immediately 3Ј to the codon for the Ile residue at the interface between the extracellular and transmembrane domains of the ␤ polypeptide. In the construction of the chimeric proteins, linkers of six amino acid residues were introduced at the junctions between the end of the TCR ␣ and ␤ and the mature ␥ and polypeptides, respectively (Fig. 1B) .
A similar approach was used to modify the genes encoding the I-E ␣ and ␤ chains. A KpnI restriction site and linker was inserted immediately 3Ј to the interface between the extracellular and transmembrane domains of the I-E ␤ polypeptide. The 5Ј regions of the gene had already been modified to encode the MCC peptide (18) and also already expressed an EcoRI site. The I-E␣ chain was modified by introduction of a HindIII
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restriction enzyme endonuclease site immediately 3Ј to the codon at the interface between the extracellular and transmembrane domains.
The baculovirus expression vector used was previously described (18) . This vector has two separate viral promoters, polyhedron and P10, allowing simultaneous expression of both chimeric polypeptide chains in the same cell (Fig. 1A) . The expression vector was digested with XhoI and KpnI and 2C TCR ␤ /Ig or I-E ␣ /Ig was inserted downstream of the P10 promoter (Fig. 1A) . Subsequently, the 2C TCR ␣ /Ig␥1 or MCC I-E ␤ /Ig␥1 was inserted into EcoRI/SphI sites downstream of the polyhedron promoter. The signal sequence for 2C TCR 2 IgG and MCC I-E k 2 IgG, ER localization came from the endogenous signal sequences associated with the native TCR and I-E proteins, respectively.
Mutagenesis
For mutagenesis cDNA encoding the individual polypeptides were subcloned into pSP72 and pSP73 vectors (Promega, Madison, WI). Oligonucleotidedirected mutagenesis was performed using the Chameleon kit (Stratagene, La Jolla, CA). All mutations were confirmed by sequencing.
Oligo nucleotides used to introduce the above mutations were 5Ј IgG1 mutation, ctgtcagtaactgcaggtgtccactctggtaccagcggtgaggttcagcttcagcagtctggagc; 3Ј IgG1 mutation, agcctctcccactctcctggtaaatgagcatgctctcagtgtccttggagccctctggtc; 5Ј Igk mutation, ctgttgctctgttttcaaggtaccaggtgtggaagcttgggaggatctgatatccagatgacgcaaatccatcc; 3Ј Igk mutation, gtcaagagcttcaacaggaatgagtgttagggtaccagacaaaggtcctgagacgccaccaccagc; 3Ј 2C TCR ␣ mutation, cagatatgaacctaaactttcaaggaggaggtacctgtcagttatgggactccgaatc; 5Ј 2C TCR ␤ mutation, ccaaagagaccagtatcctgactcgaggaagcatgtctaacactgccttc; 3Ј 2C TCR␤ mutation, ctgcaaccatcctctatgagatcggaagcttaggatctggtacctactggggaaggccaccctatatgc; 3Ј I-E d ␣ mutation, ggtagcgaccggcgctcagctggaattcaagcttccattctctttagtttctgggaggagggt; and 3Ј I-E k ␤ mutation, gcacagtccacatctgcacagaacaagggaggaggtaccggggatccggttattagtacatttattaag.
Molecular Modeling
The 2C TCR 2 IgG structure was modeled and linkers regions regularized using Quanta 4.1/CHARMm (Molecular Simulations Inc.). Coordinates for the IgG1 were obtained from the PDB (1IgGY) and for the 2C TCR (1TCR), respectively.
Biochemical Analysis of Chimeras
The conformational integrity of the chimeric molecules was assayed by ELISA using antibodies specific for each moiety of the protein. The primary antibody used was specific for murine IgG1 Fc. The secondary antibody used was either a biotinylated H57, a hamster mAb specific for a conformational epitope expressed on the ␤ chain of murine TCR (19) , or 1B2 (20, 21) , a murine mAb specific for a clonotypic epitope expressed on 2C TCR. I-E k 2 Ig was assayed using biotinylated 14.4.4, an anti-I-E ␣ chain-specific mAb, as the secondary antibody. SDS-PAGE analysis of the chimeric protein was preformed as described (22) . Samples were electrophoresed through a 10% SDSpolyacrylamide gel.
Peptide Loading of Cells, Flow Microfluorometry, and Immunohistochemistry
RMA-S L d cells, a cell line that is defective in antigen processing and expresses functionally "empty" class I MHC on the cell surface, were loaded with peptides as described (22) . For analysis of 2C TCR 2 For staining of MCC-specific hybridoma cells, MCC I-E k 2 Ig (5 g) was incubated with 1 ϫ 10 6 cells for 1 h at 4°C and washed, followed by incubation with goat antimouse IgG 1 conjugated to RPE for an additional 1 h. Hybridoma cells were then washed 2ϫ and analyzed by flow cytometry.
For immunohistochemistry experiments, L d -expressing L cells were plated on coverslips overnight. Cells were incubated with peptides QL9 or MCMV (100 M) for 1 h, washed with HBSS, and fixed in 4% PFA for 30 min. Slides were quenched in 0.25% ammonium chloride for 5 min, fixed in methanol/acetone, and blocked with 1% BSA overnight. For staining 2C TCR 2 IgG was "airfuged," 80K for 1 h, and diluted to 10 g/ml in 1% BSA. Coverslips were incubated with 2C TCR 2 IgG for 90 min at 4°C, washed, and then incubated with Cy-3-conjugated donkey anti-mouse Ig.
T Cell Stimulation Assay
Various concentrations of soluble MCC I-E k 2 Ig or the murine anti CD3-mAb, 2C11, were immobilized on sterile Immulon 4 plates (Dynatech, Burlington, MA) overnight at 4°C. Following two washes, either the MCC-specific 5KC cells or the control ovalbumin-specific DO11.10 cells (1 ϫ 10 5 /well) were added in 250 l of culture medium and incubated for 20 -24 h at 37°C. IL-2 was measured by ELISA (R&D, Minneapolis, MN).
RESULTS
Construction of a Vector for Expressing Soluble Divalent Analogs of Heterodimeric Transmembrane Proteins
Characteristics of a general system for expression of soluble divalent analogs of heterodimeric proteins include relative simplicity and broad applicability. To accomplish this, IgG was chosen as a molecular scaffold because it is divalent by nature and can be simply modified to serve as a molecular scaffold (13, 24 -26) . Of further advantage is the fact that the IgG scaffold should facilitate subunit pairing, folding, secretion, and stability of the covalently linked heterodimeric polypeptides. cDNA encoding the Ig heavy and light chains was modified immediately 5Ј of the coding region for the mature variable domains on the heavy and light chain polypeptides, respectively (Fig. 1) . These modifications allow for genetic linkage of the cDNA encoding the polypeptides of interest to the amino terminal-encoding regions of the mature immunoglobulin polypeptides. Polypeptide X is attached via a short six amino acid linker (GSLGGS) to the amino terminal end of the variable region of the Ig chain, while polypeptide Y is attached via another six amino acid linker (GGGTSG) to the amino terminus of the variable region of the Ig␥ chain (see Fig. 1B for a schematic representation of the chimeric molecule.)
We analyzed the utility of the Ig scaffold for producing two classes of heterodimers, TCR and class II ␣,␤ heterodimers. The TCR heterodimer was derived from the well-characterized alloreactive, class I-specific 2C CTL clone (21, 27) which is specific for a naturally processed endogenous peptide, p2Ca, derived from ␣-ketoglutarate dehydrogenase bound by the murine class I molecule H-2 L d (27) . This system was of interest since both higher affinity, peptide QL9, and lower affinity, peptide variants of p2Ca have been characterized (see Materials and Methods) (23, 28, 29) . The class II MHC heterodimer was derived from the murine class II molecule I-E k that has been previously modified to also encode a nominal peptide antigen derived from moth cytochrome C (18, 30) . Soluble divalent TCR (2C TCR 2 Ig) was generated by linking cDNA encoding the extracellular domains of TCR ␣ or ␤ chains to cDNA encoding Ig␥1 heavy and light chain polypeptides, respectively (Fig. 1A) . For expression of soluble divalent class II MHC molecules ( MCC I-E k 2 IgG), cDNAs encoding the extracellular domains of MCC I-E k ␤ and I-E␣ chains were genetically linked to cDNA encoding the Ig␥ 1 heavy and light chain polypeptides, respectively. The constructs were cloned into a dual promoter baculovirus expression vector (Fig. 1A) (18) (Fig. 1C) . First, assuming an extended linker, there is no steric hindrance imposed by linking the TCR molecule to the Ig polypeptides. The approximate mean distance between the TCR and Ig polypeptides is 22 Å. There is also a fair amount of flexibility associated with the linker which is probably critical for its function. In addition the model highlights the importance of the Ig hinge region in conferring flexibility in binding of cognate cell surface ligands.
Biochemical Characterization of Divalent Chimeras
Expression and conformational integrity of the chimeric molecules was assayed by ELISA. Cells infected with baculovirus viral stocks containing the transfer vectors encoding the 2C TCR 2 IgG and MCC I-E k 2 IgG constructs secrete 0.5-2 g/ml of an Ig-like material 3-4 days postinfection. Conformational epitopes of 2C TCR 2 IgG are intact as detected by a mAb H57, specific for a TCR C␤ epitope, as well as with an anticlonotypic mAb, 1B2, specific for the 2C TCR ( Fig. 2A ; top and middle panels). Soluble divalent class II molecules, MCC I-E k 2 IgG, are recognized by the conformationally dependent mAb, 14.4.4, specific for an ␣ chain determinant only expressed on intact I-E molecules ( Fig. 2A ; bottom panel). The purified chimeric Ig proteins also have the expected molecular weights as analyzed by SDS-PAGE (Fig. 2B) . Taken together, these data indicate that 2C TCR 2 IgG and MCC I-E k 2 IgG are intact chimeric molecules that in solution possess conformational epitopes associated with the native transmembrane proteins.
Peptide Specificity of 2C TCR 2 IgG
To define the specificity and sensitivity of 2C TCR 2 IgG recognition for peptide/MHC complexes, we compared the staining efficacy of soluble divalent 2C TCR 2 IgG to soluble monovalent 2C TCR in flow cytometry. Binding of 2C TCR 2 IgG to a high-affinity cognate ligand, QL9-loaded L d molecules, was very sensitive and could be detected even at the lowest concentration tested, 1 nM (Fig. 3A) (23) . Thus, there were no peptides detected by SPR that were not also recognized by 2C TCR 2 IgG in the flow cytometry based assay. Together these data indicate that 2C TCR 2 IgG is both a specific and sensitive probe for cognate ligands.
Intracellular Localization of Peptide MHC Complexes
In addition to using TCR 2 IgG to stain cells by flow cytometry we also analyzed the ability to use TCR 2 IgG TCR 2 IgG. Prominent staining activity was seen in the ER as evidenced by vesicular staining pattern, characteristic of ER localization (Fig. 4) . Control peptide, MCMV, pulsed cells showed only background 2C TCR 2 IgG staining. 2C TCR 2 IgG staining was largely restricted to intracellular sites where MHC molecules was found (data not shown). These data suggest that peptide loading primarily occurs in the ER. This finding extends other experiments using peptide-specific MHC-dependent mAb that also indicate that exogenously added peptides load MHC molecules in the ER (31) and show the potential for using these reagents in immunofluorescence studies.
MCC I-E k 2 IgG Binds and Activates Cognate T Cell Hybridoma
To assess the interaction of soluble divalent class II I-E analogs with antigen-specific T cells, we determined whether MCC I-E k 2 IgG could stain antigen-specific T cell hybridomas.
MCC I-E k 2 IgG binds specifically to 5KC, an MCC-specific, I-E k -restricted T cell hybridoma (Fig. 5) . 
DISCUSSION
To enhance our ability to analyze and regulate antigen-specific immune responses we have designed a general system for expression of soluble divalent analogs of both MHC class II and TCR molecules, using Ig as a molecular scaffolding structure. One important role the IgG scaffold serves is appositioning the two heterodimers so that the complex can engage its cognate ligands. It does this with the intrinsic flexibility afforded both by the immunoglobulin hinge region and potentially by the linker which likely facilitate TCR or MHC moieties binding their cognate ligands on cell surface membranes.
Other approaches have been developed to generate probes for antigen-specific T cells. One approach has been to generate high-affinity, anticlonotypic mAb. Anticlonotypic mAb discriminate on the basis of specific TCR V␣ and V␤ conformational determinants that are not directly related to antigenic specificity. Therefore, an anticlonotypic antibody will interact with only one of potentially many different clonotypic T cells specific for the antigen that develop during an immune response. In contrast multivalent peptide/class II MHC complexes, as reported here, exploit the natural antigenic specificity and will detect many different clonotypic T cells specific for a given antigen.
An alternative approach for expressing multivalent class I MHC molecules using strepavidin has been reported (15) . A distinct advantage of the strepavidin system is that it permits coordination of theoretically up to four biotinylated peptide/MHC complexes. This approach has been developed for peptide/class I MHC complexes (15) and recently also reported for class II complexes (32, 33) . In this system there appears to be a requirement for four peptide/MHC complexes although the definition of the minimal requirement for stable association has not yet been reported. Using Ig as a scaffolding structure allows expression of two peptide/ MHC complexes which are sufficient for stable binding to MCC-specific T cells; a system where the TCR interaction with monovalent peptide/MHC complexes has been characterized as an intrinsically low-affinity one, 50 M (34, 35) . The intrinsic flexibility associated with the Ig hinge region, a region that has been adapted during evolution to maximize binding of each Ig arm to its cognate ligand, may explain why stable association of soluble divalent pep MHC 2 Ig complexes occurs when using Ig as a scaffolding structure.
The development of reagents that differentiate between specific peptide/MHC complexes has also been an area of extensive research. Recently investigators have used soluble monovalent TCR to stain cells by crosslinking them with avidin after they have been bound to the cell (7). Another approach has been to generate mAb that differentiate between MHC molecules on the basis of peptides resident in the groove. While conventional approaches have produced only a few such antibodies with anti-peptide/MHC specificity (36 -38) , two new approaches have been developed to obtain peptide-specific, MHC-dependent mAb (39 -41) . Where reported, the affinity of these mAb for specific peptide/MHC complexes has been of intermediate strength (10 -100 nM) (39, 40) comparable to those measured using TCR 2 IgG (14) .
A distinct advantage of soluble TCR 2 IgG complexes over generation of mAb that differentiate between specific peptide/MHC complexes is that TCR 2 IgG complexes may be useful in defining specific ligands recognized by T cells, as their production does not require a priori knowledge of their ligand. They could have potential uses in defining ligands of ␥/␦ TCR or of undefined tumor-specific T cells. Furthermore, since T cell activation requires crosslinking of multiple TCR, interaction of TCR 2 IgG may mimic natural T cell activation. This could facilitate elucidation of biochemical interactions involved in TCR recognition of peptide/MHC complexes.
Soluble divalent class II MHC analog, MCC I-E k 2 IgG, was able to stimulate cognate T cells.
MCC I-E k 2 IgG was at least as efficient, if not more efficient, than anti-CD3 mAbs in eliciting IL-2 production and had a much greater efficiency than immobilized monovalent MCC I-E k (data not shown). However, unlike anti-CD3 mAbs the MCC I-E k 2 IgG was highly specific for its cognate T cell, suggesting that soluble divalent MHC analogs may be able to regulate antigen-specific T-cells and have a role in adoptive immunotherapy. We have presented a general approach for producing soluble divalent versions of heterodimeric proteins, such as T cell receptors and class II MHC molecules. The experimental system described here outlines an approach using divalent high-affinity ligands to study cell-cell interactions, driven by multivalent ligandreceptor interactions. Our work suggests that divalent chimeric molecules are good candidates for soluble, high-avidity analogs of proteins that could be used to probe and selectively regulate cellular responses.
